|
1
|
- 1910.1030(d)(2)(i) - Use of reusable microblading tools in the cosmetic tattoo industry
|
|
2
|
- 1910.1030(d)(2)(i) - Clarification of work practice controls when using needless connectors
|
|
3
|
- 1910.1030(d)(2)(i) - Applicability of the Bloodborne Pathogens standard during transection of the umbilical cord.
|
|
4
|
- 1910.1030(d)(2)(i) - OSHA's position on the use of Novartis' Fluvirin device.
|
|
5
|
- 1910.1030(d)(2)(i) - OSHA's position on the use of lancets or lancing devices without safety-engineered features for finger prick blood sampling in the workplace.
|
|
6
|
- 1910.1030(d)(2)(i) - Clarification of the use and selection of BBP safety devices.
|
|
7
|
- 1910.1030(d)(2)(i) - Whether the BD SmartSlip™ is an acceptable safety-engineered device under 1910.1030.
|
|
8
|
- 1910.1030(d)(2)(i) - Requirements for safety-engineered sharps for stockpiled pandemic influenza vaccines and pre-filled syringes.
|
|
9
|
- 1910.1030(d)(2)(i) - Whether shielding is required when removing Becton Dickinson's blood tubes with a Hemoguard® closure.
|
|
10
|
- 1910.1030(d)(2)(i) - "Freehand" piercing without the use of forceps or other engineering controls violates the bloodborne pathogens standards.
|
|
11
|
- 1910.1030(d)(2)(i) - Applicability of the bloodborne pathogens standard to persons who self-administer injectable medications.
|
|
12
|
- 1910.1030(d)(2)(i) - Definition of contaminated sharps; engineering controls and good work practice controls must be implemented; ECP must be reviewed annually.
|
|
13
|
- 1910.1030(d)(2)(i) - Containment and disposal requirements for disposable razors used in long-term health care facilities for personal grooming.
|
|
14
|
- 1910.1030(d)(2)(i) - Limiting factors for implementing the use of engineering controls, i.e., safety scalpels, under the Bloodborne Pathogens standard.
|
|
15
|
- 1910.1030(d)(2)(i) - Bloodborne Pathogens Standard application to bifurcated needles; acceptability and appropriateness of safety bifurcated needles.
|
|
16
|
- 1910.1030(d)(2)(i) - Clarification from OSHA regarding the use of the NeedleguardTM in a hospital environment.
|
|
17
|
- 1910.1030(d)(2)(i) - Recapping of contaminated needles used in body piercing.
|
|
18
|
- 1910.1030(d)(2)(i) - Engineering control requirements for allergy and immunization injections.
|
|
19
|
- 1910.1030(d)(2)(i) - Needlestick Safety and Prevention Act and the requirement to include safety-engineered sharps devices in pre-packaged surgical kits or trays.
|
|
20
|
- 1910.1030(d)(2)(i) - Safer medical devices must be selected based on employee feedback and device effectiveness, not Group Purchasing Organizations.
|
|
21
|
- 1910.1030(d)(2)(i) - Needle destruction device use as an engineering control for the Bloodbore Pathogens standard.
|
|
22
|
- 1910.1030(d)(2)(i) - Response to the American Academy of Pediatrics regarding the Needlestick Safety and Prevention Act.
|
|
23
|
- 1910.1030(d)(2)(i) - Use of engineering and work practice controls during pouring of blood or OPIM.
|
|
24
|
- 1910.1030(d)(2)(i) - Labeling requirements under the HAZCOM and Laboratory standards;use of safe needle devices.
|
|
25
|
- 1910.1030(d)(2)(i) - Engineering controls must be used to prevent needlesticks where feasible.
|